Non-bacterial infections
Antifungal agentsTopical agents
- Treatment of fungal infections of skin, ear and eye.
- Successful treatment depends on management which limits infection, eg grooming, clipping, isolation, cleansing agents for animal and environment.
- Systemic agents may be used also.
Pruritic skin disease
Others
Ear infections
- Usually combination preparations.
Yeasts
Eye infections
- Conditions may be superficial, eg mycotic keratitis
or intra-ocular, eg mycotic endophthalmitis
. - Most topical preparations have poor corneal penetration, so systemic preparations preferred.
Aspergillosis
- For nasal infection
with Aspergillus fumigatus
: combination treatment with systemic ketoconazole *, surgery and intrasinus treatment using enilconazole *
. - May also treat with intranasally instilled clotrimazole
.
Systemic agents
- Griseofulvin
. - For dermatophyte infections.
- Deposited in keratin precursor cells → stratum corneum of skin, hair and nails → prevents fungal invasion of new cells.
- Absorption enhanced by administration with fatty meal.
- Treatment usually minimum 3-4 weeks → 12 weeks.
May be teratogenic: avoid handling by pregnant women
Imidazoles
- Interfere with biosynthesis of ergosterol.
- Fungistatic.
- Broad spectrum.
- Clotrimazole
. - Topical.
- Malassezia infection
(as 1% solution). - Miconazole
. - Topical.
- Too toxic for treatment of systemic fungal infections.
- Ketoconazole *
. - Active against fungi and yeasts, some gram-positive bacteria.
- For systemic candidiasis and refractory dermatophytoses.
- Administration with food may → nausea. Do not administer with antacids, which can reduce its absorption.
- Interferes with mammalian adrenal and gonadal steroid synthesis → alternative treatment for Cushing's disease (hyperadrenocorticism
).
May be teratogenic; prolonged administration may result in liver damage - Itraconazole *
. - Systemic candidiasis, refractory dermatophytoses, sytemic fungal infections.
Do not administer with antacids, which can reduce its absorption. - Fluconazole
. - Systemic candidiasis, refractory dermatophytosis, systemic fungal infections.
- Absorption not affected by antacids.
- Nystatin *
. - Gastrointestinal candidiasis
. - Amphotericin *
. - Against yeasts and fungi. Used for life-threatening or refractory systemic fungal infections.
- Nephrotoxic. Requires saline diuresis. Liposomal formulation markedly reduces nephrotoxicity.
Antiviral agents
- Used mainly in ophthalmology.
Eye infections
Antiprotozoal agents
Coccidiosis
Neosporosis
- Neospora caninum
. - Clindamycin
. - Co-trimazine (trimethoprim + sulfadiazine) - see above, also in combination with pyrimethamine.
Toxoplasmosis
- Clindamycin
. - Co-trimazine (trimethoprim + sulfaziazine) - see above, also in combination with pyrimethamine.
Giardiasis
Sources
Publications
Refereed papers
- Recent references from PubMed.
Other sources of information
- Lappin M R (2000) Protozoal and miscellaneous infections. In: Textbook of Veterinary Internal Medicine.5th edn. Ettinger S J & Feldman E C (eds). W B Saunders, Philadelphia. pp 408-417.
- Taboada J (2000) Systemic mycoses. In: Textbook of Veterinary Internal Medicine.5th edn. Ettinger S J & Feldman E C (eds). W B Saunders, Philadelphia. pp 453-476.
- Plumb D C (1999) Veterinary Drug Handbook. 3rd edn. Iowa State University Press, Ames, Iowa.



